Curevac N.V. sell Traumtanz
Start price
16.10.20
/
50%
€44.88
Target price
16.10.20
€40.00
Performance (%)
1.20%
End price
16.10.20
€45.42
Summary
This prediction ended on 16.10.20 with a price of €45.42. The SELL prediction by Traumtanz shows the price for Curevac N.V. slightly increased by 1.20% during the runtime of the prediction. Traumtanz has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Curevac N.V. | 5.450% | 5.450% | - | - |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to Traumtanz what are the pros and cons of Curevac N.V. for the foreseeable future?
Pros
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
EBIT growth > 30% per year expected
Fair valuation
Standard Investments for future growth
Small cyclical dependencies
Cons
Comments by Traumtanz for this prediction
In the thread Curevac N.V. diskutieren
Sell mit Kursziel 40,0
In the thread Trading Curevac N.v.
Sell beendet
Stopped prediction by Traumtanz for Curevac N.V.
Curevac N.V.
Start price
Target price
Perf. (%)
€72.27
28.11.20
28.11.20
-
28.11.21
28.11.21
51.90%
10.12.20
10.12.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€65.01
14.11.20
14.11.20
-
6.54%
26.11.20
26.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€60.99
13.11.20
13.11.20
€63.00
6.59%
14.11.20
14.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€59.80
13.11.20
13.11.20
€60.00
1.99%
13.11.20
13.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€57.49
12.11.20
12.11.20
€60.00
4.02%
13.11.20
13.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€54.30
12.11.20
12.11.20
€57.00
5.87%
12.11.20
12.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€50.44
10.11.20
10.11.20
€55.00
4.48%
12.11.20
12.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€48.01
10.11.20
10.11.20
€55.00
5.07%
10.11.20
10.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€45.42
16.10.20
16.10.20
€40.00
04.11.21
04.11.21
5.70%
10.11.20
10.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€68.00
15.08.20
15.08.20
-
19.09.20
19.09.20
-35.29%
19.09.20
19.09.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation